Axsome Therapeutics Inc
AXSM152.650USD
+5.650+3.84%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
7.68BMarket Cap
LossP/E TTM
Axsome Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
385.69M
42.53%
EPS(YoY)
-5.99
-13.82%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its total revenue reached 385.69M, with a year-on-year change of 42.53%.
What is the Earnings Per Share (EPS) of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -5.994, with a year-on-year change of -13.82%.
What is the net income of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its net income was -287.22M, with a year-on-year change of -20.05%.
What is the net margin of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its net profit margin was -74.47%, with a year-on-year change of 15.77%.
What is the gross margin of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its gross margin was 89.71%, with a year-on-year change of 1.93%.
What is the debt-to-asset ratio of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 32.55%, with a year-on-year change of 7.54%.
What is the Return on Equity (ROE) of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -231.63%, with a year-on-year change of -45.49%.
What is the Return on Assets (ROA) of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -49.66%, with a year-on-year change of 4.55%.
What is the operating profit of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its operating profit was -252.44M, with a year-on-year change of -38.01%.
What are the current assets of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its current assets were 485.06M, with a year-on-year change of -3.81%.
What are the total assets of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its total assets of Axsome Therapeutics Inc were 568.50M, with a year-on-year change of -3.36%.
What are the total liabilities of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its total liabilities of Axsome Therapeutics Inc were 511.48M, with a year-on-year change of 28.75%.
What is the total equity of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its total equity of Axsome Therapeutics Inc was 57.02M, with a year-on-year change of -70.15%.
What is the net operating income of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its net operating income of Axsome Therapeutics Inc was -287.22M, with a year-on-year change of -20.05%.
What is the net investment of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its net investment of Axsome Therapeutics Inc was -270.00K, with a year-on-year change of 53.61%.
What is the net financing of Axsome Therapeutics Inc?
According to Axsome Therapeutics Inc's FY2024 earnings report, its net financing of Axsome Therapeutics Inc was 57.84M, with a year-on-year change of -82.53%.
